Fuller & Thaler Asset Management
BMRN icon

Fuller & Thaler Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Fuller & Thaler Asset Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$49.3M Buy
897,516
+61,119
+7% +$3.36M 0.18% 189
2025
Q1 		$59.1M Buy
+836,397
New +$59.1M 0.23% 157